80/100BNovartis company profile
- CEO
- Vasant Narasimhan
- Employees
- 75,267
- Headquarters
- Lichtstrasse 35, Basel, BS 4056, CH
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- IPO date
- 7 Nov 1996
- Stock exchange
- NYSE
- ISIN
- US66987V1098
Website:novartis.com
About the company
Novartis AG is a holding company, which engages in the business of developing, manufacturing, and marketing healthcare products. Its product portfolio is heavily focused on innovative prescription medicines, especially oncology, immunology, neuroscience, and cardiovascular diseases, supplemented by established older brands and a wide range of specialized therapies. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.
Employees
Novartis had about 75,267 employees at the end of fiscal year 2025 (31 December 2025), by its annual report. That is 0.8% fewer than a year before.
Employees at each fiscal year end, as the company reports them in its annual report (10-K); revenue and net income per employee are the fiscal year's over that count.
Who owns Novartis
Institutions such as funds, banks and insurers held 7.1% of Novartis's shares on 30 June 2026, 1,675 of them reporting holdings to the SEC; the rest is held by individual investors and other shareholders.
Shares free to trade
Closely held shares belong to insiders, founders and owners of more than 5%, and seldom change hands. The free float is the rest: the shares anyone can buy and sell.
Common questions about Novartis
Source: Financial Modeling Prep